The effect of combined tocolysis on in vitro uterine contractility in preterm labour

Animal models have confirmed high efficiency of combined tocolytic treatment in preterm labour. In humans, the recommended doses of tocolytic drugs prolong pregnancy in threatened preterm labour. The aim of the study was to evaluate the inhibitory effect of dual combinations of atosiban, nifedipine...

Full description

Saved in:
Bibliographic Details
Published in:Advances in medical sciences 2011-06, Vol.56 (1), p.88-94
Main Authors: Kuć, P, Laudański, P, Pierzyński, P, Laudański, T
Format: Article
Language:English
Subjects:
atosiban
celecoxib
combined tocolytic treament
Female
Humans
In Vitro Techniques
Myometrium - drug effects
Myometrium - physiopathology
nifedipine
Obstetric Labor, Premature - drug therapy
Obstetric Labor, Premature - physiopathology
Pregnancy
preterm labour
Tocolytic Agents - pharmacology
Uterine Contraction - drug effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Animal models have confirmed high efficiency of combined tocolytic treatment in preterm labour. In humans, the recommended doses of tocolytic drugs prolong pregnancy in threatened preterm labour. The aim of the study was to evaluate the inhibitory effect of dual combinations of atosiban, nifedipine and celecoxib on human myometrial strips contractility on the in vitro model of preterm labour. Two groups of patients who delivered by cesarean section were involved in the study: 36 patients who delivered preterm between the 24th and 34th week of pregnancy and 40 patients who delivered at term. Myometrial samples were obtained from the lower uterine segment during cesarean sections. Contractile activity was recorded with digital software for each drug combination: atosiban/nifedipine; atosiban/celecoxib, nifedipine/celecoxib. Tocolytic efficiency of the drug combinations was assessed using IC50 parameter – a molar drug concentration inhibiting 50% of contractility. The atosiban/nifedipine combination has shown additive tocolytic effect on myometrial strips contractility in preterm and term patients. The other combinations: atosiban/celecoxib and nifedipine/celecoxib presented only antagonistic effects in both studied groups. The effect of the combined therapy on human myometrial contractility presented in the study could be a base for further in vivo clinical trials.
ISSN:1896-1126
1898-4002
DOI:10.2478/v10039-011-0019-x